Activated mouse \(CD4^+Foxp3^−\) T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity
Wu, JunNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationWang, Xiaojuan, Yanyan Cui, Gaoxing Luo, Qinghong Wang, Jie Hu, Weifeng He, Jun Yuan, et al. 2012. Activated mouse \(CD4^+Foxp3^−\) T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity. Cell Research 22(12): 1696-1706.
AbstractThe regulatory activities of mouse \(CD^4+Foxp3^+\) T cells on various immune cells, including NK cells, have been well documented. Under some conditions, conventional \(CD4^+Foxp3^−\) T cells in the periphery are able to acquire inhibitory function on other T cells, but their roles in controlling innate immune cells are poorly defined. As a potential cellular therapy for cancer, ex vivo activated \(CD4^+Foxp3^−\) effector T cells are often infused back in vivo to suppress tumor growth and metastasis. Whether such activated T cells could affect NK-cell control of tumorigenesis is unclear. In the present study, we found that mitogen-activated \(CD4^+Foxp3^−\) T cells exhibited potent suppressor function on NK-cell proliferation and cytotoxicity in vitro, and notably facilitated B16 melanoma metastasis in vivo. Suppression of NK cells by activated \(CD4^+Foxp3^−\) T cells is cell-cell contact dependent and is mediated by Qa-1:NKG2A interaction, as administration of antibodies blocking either Qa-1 or NKG2A could completely reverse this suppression, and significantly inhibited otherwise facilitated melanoma metastasis. Moreover, activated \(CD4^+Foxp3^−\) cells from Qa-1 knockout mice completely lost the suppressor activity on NK cells, and failed to facilitate melanoma metastasis when transferred in vivo. Taken together, our findings indicate that innate anti-tumor response is counter regulated by the activation of adaptive immunity, a phenomenon we term as “activation-induced inhibition”. Thus, the regulatory role of activated \(CD4^+Foxp3^−\) T cells in NK-cell activity must be taken into consideration in the future design of cancer therapies.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:10582119
- HMS Scholarly Articles